← Back to Search

Prebiotic Fiber

Prebiotic for Epilepsy (EPBiome Trial)

Phase 4
Waitlist Available
Research Sponsored by British Columbia Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 2-18.
Attended the epilepsy clinic for a minimum of 6 months.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

EPBiome Trial Summary

Role of the Gut Microbiota in Pediatric Epilepsy

Eligible Conditions
  • Epilepsy

EPBiome Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

EPBiome Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Short Chain Fatty Acid (SCFA) levels in stool
Change in alpha and beta bacterial diversity measures in stool
Secondary outcome measures
Seizure frequency

EPBiome Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: PrebioticExperimental Treatment1 Intervention
Oligofructose-enriched inulin 4 grams daily for ≤ age 6; or 8 grams daily for >6 years
Group II: PlaceboPlacebo Group1 Intervention
Maltodextrin 4 grams daily for ≤ age 6; or 8 grams daily for >6 years
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Prebiotic
2016
Completed Phase 2
~720

Find a Location

Who is running the clinical trial?

British Columbia Children's HospitalLead Sponsor
25 Previous Clinical Trials
15,186 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~12 spots leftby Mar 2025